Correspondence to editorial on "Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma".
作者信息
Liu Yang, Peng Fan, Wang Siyuan, Xing Jinliang
机构信息
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and Department of Physiology and Pathophysiology, Fourth Military Medical University, Xi'an, China.
Department of Clinical Diagnosis, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
出版信息
Clin Mol Hepatol. 2025 Apr;31(2):e166-e168. doi: 10.3350/cmh.2024.1185. Epub 2025 Jan 6.
Abstract
摘要
相似文献
1
Correspondence to editorial on "Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma".致关于“循环游离线粒体DNA的异常片段组学特征可实现肝细胞癌的早期检测和预后预测”的社论的信函。
Clin Mol Hepatol. 2025 Apr;31(2):e166-e168. doi: 10.3350/cmh.2024.1185. Epub 2025 Jan 6.
2
Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma.循环游离线粒体DNA的异常片段组学特征有助于肝细胞癌的早期检测和预后预测。
Clin Mol Hepatol. 2025 Jan;31(1):196-212. doi: 10.3350/cmh.2024.0527. Epub 2024 Oct 15.
3
Circulating cell-free mitochondrial DNA for diagnosing hepatocellular carcinoma and assessing prognosis: Editorial on "Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma".循环游离线粒体DNA用于诊断肝细胞癌和评估预后：关于“循环游离线粒体DNA的异常片段组学特征能够实现肝细胞癌的早期检测和预后预测”的社论
Clin Mol Hepatol. 2025 Apr;31(2):599-602. doi: 10.3350/cmh.2024.1133. Epub 2024 Dec 26.
4
Reply to correspondence on "Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma".对关于“循环游离线粒体DNA的异常片段组学特征能够实现肝细胞癌的早期检测和预后预测”的通信的回复
Clin Mol Hepatol. 2025 Apr;31(2):e215-e217. doi: 10.3350/cmh.2025.0035. Epub 2025 Jan 16.
5
Aberrant fragmentomic features of circulating cell-free mitochondrial DNA as novel biomarkers for multi-cancer detection.循环游离线粒体DNA的异常片段组学特征作为多癌检测的新型生物标志物。
EMBO Mol Med. 2024 Dec;16(12):3169-3183. doi: 10.1038/s44321-024-00163-6. Epub 2024 Oct 30.
6
Early detection of colorectal cancer using aberrant circulating cell-free mitochondrial DNA fragmentomics.利用异常循环游离线粒体DNA片段组学早期检测结直肠癌
Gut. 2025 May 7;74(6):961-970. doi: 10.1136/gutjnl-2024-333533.
7
Ultra-short cell-free DNA fragments enhance cancer early detection in a multi-analyte blood test combining mutation, protein and fragmentomics.超短细胞游离 DNA 片段增强了一种结合突变、蛋白质和片段组学的多分析物血液检测的癌症早期检测能力。
Clin Chem Lab Med. 2023 Sep 8;62(1):168-177. doi: 10.1515/cclm-2023-0541. Print 2024 Jan 26.
8
Enhanced Detection of Landmark Minimal Residual Disease in Lung Cancer Using Cell-free DNA Fragmentomics.基于游离 DNA 片段组学的肺癌微小残留病灶的高灵敏度检测
Cancer Res Commun. 2023 May 30;3(5):933-942. doi: 10.1158/2767-9764.CRC-22-0363. eCollection 2023 May.
9
Integrated fragmentomic profile and 5-Hydroxymethylcytosine of capture-based low-pass sequencing data enables pan-cancer detection via cfDNA.基于捕获的低通量测序数据的整合片段组学图谱和5-羟甲基胞嘧啶能够通过cfDNA进行泛癌检测。
Transl Oncol. 2023 Aug;34:101694. doi: 10.1016/j.tranon.2023.101694. Epub 2023 May 18.
10
Cell-free epigenomes enhanced fragmentomics-based model for early detection of lung cancer.基于无细胞表观基因组增强片段组学的肺癌早期检测模型
Clin Transl Med. 2025 Feb;15(2):e70225. doi: 10.1002/ctm2.70225.
引用本文的文献
1
Reply to correspondence on "Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma".对关于“循环游离线粒体DNA的异常片段组学特征能够实现肝细胞癌的早期检测和预后预测”的通信的回复
Clin Mol Hepatol. 2025 Apr;31(2):e215-e217. doi: 10.3350/cmh.2025.0035. Epub 2025 Jan 16.
本文引用的文献
1
Circulating cell-free mitochondrial DNA for diagnosing hepatocellular carcinoma and assessing prognosis: Editorial on "Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma".循环游离线粒体DNA用于诊断肝细胞癌和评估预后：关于“循环游离线粒体DNA的异常片段组学特征能够实现肝细胞癌的早期检测和预后预测”的社论
Clin Mol Hepatol. 2025 Apr;31(2):599-602. doi: 10.3350/cmh.2024.1133. Epub 2024 Dec 26.
2
Prospective appraisal of clinical diagnostic algorithms for hepatocellular carcinoma surveillance in Chinese patients with chronic hepatitis B infection.前瞻性评估中国慢性乙型肝炎感染患者肝细胞癌监测的临床诊断算法。
Sci Rep. 2024 Nov 22;14(1):28996. doi: 10.1038/s41598-024-80257-w.
3
Aberrant fragmentomic features of circulating cell-free mitochondrial DNA as novel biomarkers for multi-cancer detection.循环游离线粒体DNA的异常片段组学特征作为多癌检测的新型生物标志物。
EMBO Mol Med. 2024 Dec;16(12):3169-3183. doi: 10.1038/s44321-024-00163-6. Epub 2024 Oct 30.
4
Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma.循环游离线粒体DNA的异常片段组学特征有助于肝细胞癌的早期检测和预后预测。
Clin Mol Hepatol. 2025 Jan;31(1):196-212. doi: 10.3350/cmh.2024.0527. Epub 2024 Oct 15.
5
Fragmentomic analysis of circulating tumor DNA-targeted cancer panels.循环肿瘤 DNA 靶向肿瘤面板的片段组学分析。
Ann Oncol. 2023 Sep;34(9):813-825. doi: 10.1016/j.annonc.2023.06.001. Epub 2023 Jun 16.
6
Cell-Free DNA Fragmentomics: The Novel Promising Biomarker.无细胞游离 DNA 片段组学：新型有前途的生物标志物。
Int J Mol Sci. 2023 Jan 12;24(2):1503. doi: 10.3390/ijms24021503.
7
Multidimensional Cell-Free DNA Fragmentomic Assay for Detection of Early-Stage Lung Cancer.多维游离细胞 DNA 片段组学分析检测早期肺癌。
Am J Respir Crit Care Med. 2023 May 1;207(9):1203-1213. doi: 10.1164/rccm.202109-2019OC.
8
Epidemiology of Hepatocellular Carcinoma.肝细胞癌的流行病学
Hepatology. 2021 Jan;73 Suppl 1(Suppl 1):4-13. doi: 10.1002/hep.31288. Epub 2020 Nov 24.
9
Genome-wide cell-free DNA fragmentation in patients with cancer.癌症患者的全基因组游离 DNA 片段化。
Nature. 2019 Jun;570(7761):385-389. doi: 10.1038/s41586-019-1272-6. Epub 2019 May 29.
10
Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment.肝硬化对各种肝病发生肝细胞癌的实际影响——荟萃分析评估。
Cancer Med. 2019 Mar;8(3):1054-1065. doi: 10.1002/cam4.1998. Epub 2019 Feb 21.
Zotero 插件